SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-017937
Filing Date
2019-09-13
Accepted
2019-09-13 13:20:22
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_inspyrtherapeutics.htm 10-Q 984716
2 CERTIFICATION f10q0619ex31-1_inspyrtherap.htm EX-31.1 7379
3 CERTIFICATION f10q0619ex31-2_inspyrtherap.htm EX-31.2 7451
4 CERTIFICATION f10q0619ex32-1_inspyrtherap.htm EX-32.1 4858
5 CERTIFICATION f10q0619ex32-2_inspyrtherap.htm EX-32.2 4801
  Complete submission text file 0001213900-19-017937.txt   3131310

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20190630.xml EX-101.INS 380379
7 XBRL SCHEMA FILE nspx-20190630.xsd EX-101.SCH 38574
8 XBRL CALCULATION FILE nspx-20190630_cal.xml EX-101.CAL 36484
9 XBRL DEFINITION FILE nspx-20190630_def.xml EX-101.DEF 113829
10 XBRL LABEL FILE nspx-20190630_lab.xml EX-101.LAB 265355
11 XBRL PRESENTATION FILE nspx-20190630_pre.xml EX-101.PRE 200133
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 191092152
SIC: 2834 Pharmaceutical Preparations